https://scholars.lib.ntu.edu.tw/handle/123456789/378104
標題: | Functionalization of mesoporous silica nanoparticles for targeting, biocompatibility, combined cancer therapies and theragnosis | 作者: | Kuthati, Y. Sung, P.-J. Weng, C.-F. CHUNG-YUAN MOU Lee, C.-H. |
關鍵字: | Biocompatibility; Combined therapies; Mesoporous silica; Nanoparticles; Targeting; Theragnosis | 公開日期: | 2013 | 卷: | 13 | 期: | 4 | 起(迄)頁: | 2399-2430 | 來源出版物: | Journal of Nanoscience and Nanotechnology | 摘要: | The advent of Nanotechnology has paved a way for improved disease treatment strategies, the most noteworthy being the mesoporous silica nanoparticles (MSNs) which have gained much recent attention in the field of cancer therapy and its diagnosis. The flaws of the current-day strategies can be overcome by this superior technology through its targeting ability in delivering drugs and image able agents specifically to the tumor sites. MSNs have unique biocompatibility features, its high surface area which contributes in large amount of drug loading and its facility to monitor size and shape of the nanoparticles are few of the positives which makes this technology an enormous asset for the field of Nanotechnology. This review paper is structured in such a way wherein we initially have discussed about the synthesis methods and various functionalization approaches for MSN followed by the different methods used for targeting cancer cells and the latest advances in controlled drug release. Some of the highlights of this review are the biocompatibility of MSNs, in vivo results of MSNs on cancer therapy. This review paper also shortly discuss about combined cancer therapies to overcome the challenges in current-day cancer treatment. Finally, we converge briefly on the recent advancements in the use of hybrid MSNs for obtaining multiple functions. Copyright ? 2013 American Scientific Publishers. |
URI: | http://www.scopus.com/inward/record.url?eid=2-s2.0-84876915310&partnerID=MN8TOARS http://scholars.lib.ntu.edu.tw/handle/123456789/378104 |
DOI: | 10.1166/jnn.2013.7363 | SDG/關鍵字: | Combined therapy; Controlled drug release; Functionalizations; High surface area; Mesoporous Silica; Mesoporous silica nanoparticles; Targeting; Theragnosis; Biocompatibility; Diseases; Loading; Nanoparticles; Nanotechnology; Oncology; Diagnosis; biomaterial; drug carrier; nanoparticle; silicon dioxide; drug combination; human; neoplasm; review; Biocompatible Materials; Drug Carriers; Drug Therapy, Combination; Humans; Nanoparticles; Neoplasms; Silicon Dioxide |
顯示於: | 化學系 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。